Middle East & Africa Glycomics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Enzymes, Instruments, Kits, and Reagents), Application (Drug Discovery and Development, Diagnostics, Immunology, Cancer, and Others), and End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Contract Research Organizations)

Code: BMIRE00027258 | Pages: 180 | Industry: Biotechnology | Date: Oct 2022 | Type: Regional

The MEA glycomics market is expected to grow from US$ 71.00 million in 2022 to US$ 140.21 million by 2028; it is estimated to grow at a CAGR of 12.0% from 2022 to 2028.

 

Glycomics is a novel method for creating medicines. It draws on the knowledge that glycans serve as the primary means of altering numerous molecules in biological systems. This alteration provides those molecules with their complete, functional form. Glycans are found in most top-selling biologics and half of the therapeutic proteins (including antibodies against COVID-19). These proteins' glycans have been tailored to improve their effectiveness, lower the dosages required, and lessen negative effects. For instance, understanding the biological functions of glycans has led to their inclusion as essential ingredients in medications for the treatment of diabetes, the prevention of blood clotting, and the improvement of in vitro fertilization. Changes in the glycans on a microbe's surface are frequently connected to the microorganisms' resistance to popular medications. This property has been used in various ways, including detecting glycans in infection samples, disabling the protective biofilms formed by the infecting bacteria, and weakening the glycan-rich cell walls of microorganisms. More than 130 uncommon genetic illnesses, many of which are fatal in childhood, are brought on by errors in how human systems metabolize glycans. Understanding the glycans responsible for some of these problems has helped develop therapies. Because they can play a crucial role in how bacteria and viruses attack humans and escape our immune systems, glycans are employed in vaccinations. Additionally, more recent research on SARS-CoV-2 has shown infection pathways that depend on the virus's usage of human glycans. Glycans determine human blood types and reactions to organ transplants or blood transfusions. The blood or organ must match the blood group to be accepted. Therefore, greater adoption of glycomics in various research areas would eventually lead to a rise in the demand for these techniques, creating more research and developmental opportunities in the longer run.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA. The MEA is expected to grow at a good CAGR during the forecast period. 

 

 MEA Glycomics Market Revenue and Forecast to 2028 (US$ Million)  

 MEA Glycomics Market Revenue and Forecast to 2028 (US$ Million)  

Get more information on this report :

 

 

MEA Glycomics Market Segmentation                 

 

The MEA glycomics market is segmented based on product, application, end user, and country. Based on product, the MEA glycomics market is segmented into enzymes, instruments, kits, and reagents. The enzymes segment dominated the market in 2022. The enzymes segment is further segmented into glycosidases, glycosyl transferases, sialyltransferases, neuraminidases, and others. The instruments segment is also segmented into mass spectrometers, MALDI-TOF, HPLC, lectin arrays, antibody arrays, and others. Similarly, the kits segment is segmented into glycan release kits, glycan labeling kits, glycan purification kits, and others. Furthermore, the reagents segment is segmented into oligosaccharides, monosaccharides, glycoproteins, and others. Based on application, the MEA glycomics market is segmented into drug discovery and development, diagnostics, immunology, cancer, and others. The drug discovery and development segment dominated the market in 2022. Based on end user, the MEA glycomics market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations. The pharmaceutical & biotechnology companies segment dominated the market in 2022. Based on country, the MEA glycomics market has been categorized into the UAE, Saudi Arabia, South Africa, and the Rest of MEA. Saudi Arabia dominated the market in 2022.   

  

Agilent Technologies, Inc.; Bruker Corporation; MERCK KGaA; New England Biolabs; Shimadzu Corporation; Takara Bio Inc.; Thermo Fisher Scientific Inc.; and Waters Corporation are among the leading companies in the MEA glycomics market.     

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        MEA Glycomics Market – By Product

1.3.2        MEA Glycomics Market – By Application

1.3.3        MEA Glycomics Market – By End User

1.3.4        MEA Glycomics Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           MEA Glycomics Market – Market Landscape

4.1         Overview

4.2         MEA PEST Analysis

4.3         Expert Opinion

5.           MEA Glycomics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increased Glycomics Research and Expanding R&D Investments

5.1.2        Rising Use of Glycomics in Various Diseases Leading to Development of New Treatment Processes

5.2         Market Restraints

5.2.1        High Cost of Equipment and Shortage of skilled Professionals

5.3         Market Opportunities

5.3.1        Wide Applications of Glycomics

5.4         Future Trends

5.4.1        New tools in Glycomics Research

5.5         Impact Analysis

6.           Glycomics Market– MEA Analysis

6.1         MEA Glycomics Market Revenue Forecast and Analysis

7.           MEA Glycomics Market Analysis – By Product

7.1         Overview

7.2         MEA Glycomics Market, By Product 2022 & 2028 (%)

7.3         Enzymes

7.3.1        Overview

7.3.2        Enzymes Revenue and Forecast to 2028 (US$ Million)

7.3.3        Glycosidases

7.3.3.1          Overview

7.3.3.2          Glycosidases - Revenue and Forecast to 2028 (US$ Million)

7.3.4        Glycosyltransferases

7.3.4.1          Overview

7.3.4.2          Glycosyltransferases - Revenue and Forecast to 2028 (US$ Million)

7.3.5        Sialyltransferases

7.3.5.1          Overview

7.3.5.2          Sialyltransferases - Revenue and Forecast to 2028 (US$ Million)

7.3.6        Neuraminidases

7.3.6.1          Overview

7.3.6.2          Neuraminidases - Revenue and Forecast to 2028 (US$ Million)

7.3.7        Others

7.3.7.1          Overview

7.3.7.2          Others- Revenue and Forecast to 2028 (US$ Million)

7.4         Instruments

7.4.1        Overview

7.4.2        Instruments - Revenue and Forecast to 2028 (US$ Million)

7.4.3        Mass Spectrometers

7.4.3.1          Overview

7.4.3.2          Mass Spectrometers- Revenue and Forecast to 2028 (US$ Million)

7.4.4        MALDI-TOF

7.4.4.1          Overview

7.4.4.2          MALDI-TOF - Revenue and Forecast to 2028 (US$ Million)

7.4.5        High-Performance Liquid Chromatography (HPLC)

7.4.5.1          Overview

7.4.5.2          High-Performance Liquid Chromatography (HPLC)- Revenue and Forecast to 2028 (US$ Million)

7.4.6        Lectin Arrays

7.4.6.1          Overview

7.4.6.2          Lectin Arrays- Revenue and Forecast to 2028 (US$ Million)

7.4.7        Antibody Arrays

7.4.7.1          Overview

7.4.7.2          Antibody Arrays - Revenue and Forecast to 2028 (US$ Million)

7.4.8        Others

7.4.8.1          Overview

7.4.8.2          Others- Revenue and Forecast to 2028 (US$ Million)

7.5         Kits

7.5.1        Overview

7.5.2        Kits - Revenue and Forecast to 2028 (US$ Million)

7.5.3        Glycan Release Kits

7.5.3.1          Overview

7.5.3.2          Glycan Release Kits - Revenue and Forecast to 2028 (US$ Million)

7.5.4        Glycan Labelling Kits

7.5.4.1          Overview

7.5.4.2          Glycan Labelling Kits - Revenue and Forecast to 2028 (US$ Million)

7.5.5        Glycan Purification Kits

7.5.5.1          Overview

7.5.5.2          Glycan Purification Kits - Revenue and Forecast to 2028 (US$ Million)

7.5.6        Others

7.5.6.1          Overview

7.5.6.2          Others- Revenue and Forecast to 2028 (US$ Million)

7.6         Reagents

7.6.1        Overview

7.6.2        Reagents - Revenue and Forecast to 2028 (US$ Million)

7.6.3        Oligosaccharides

7.6.3.1          Overview

7.6.3.2          Oligosaccharides- Revenue and Forecast to 2028 (US$ Million)

7.6.4        Monosaccharides

7.6.4.1          Overview

7.6.4.2          Monosaccharides - Revenue and Forecast to 2028 (US$ Million)

7.6.5        Glycoproteins

7.6.5.1          Overview

7.6.5.2          Glycoproteins - Revenue and Forecast to 2028 (US$ Million)

7.6.6        Others

7.6.6.1          Overview

7.6.6.2          Others- Revenue and Forecast to 2028 (US$ Million)

8.           MEA Glycomics Market Analysis – By Application

8.1         Overview

8.2         MEA Glycomics Market, By Application 2022 & 2028 (%)

8.3         Drug Discovery and Development

8.3.1        Overview

8.3.2        Drug Discovery and Development - Market Revenue and Forecast to 2028 (US$ Million)

8.4         Diagnostics

8.4.1        Overview

8.4.2        Diagnostics - Market Revenue and Forecast to 2028 (US$ Million)

8.5         Immunology

8.5.1        Overview

8.5.2        Immunology - Market Revenue and Forecast to 2028 (US$ Million)

8.6         Cancer

8.6.1        Overview

8.6.2        Cancer - Market Revenue and Forecast to 2028 (US$ Million)

8.7         Others

8.7.1        Overview

8.7.2        Others - Market Revenue and Forecast to 2028 (US$ Million)

9.           MEA Glycomics Market Analysis – By End User

9.1         Overview

9.2         MEA Glycomics Market, By End User 2022 & 2028 (%)

9.3         Pharmaceutical and Biotechnology Companies

9.3.1        Overview

9.3.2        Pharmaceutical and Biotechnology Companies - Market Revenue And Forecasts To 2028 (US$ Million)

9.4         Contract Research Organizations

9.4.1        Overview

9.4.2        Contract Research Organizations - Market Revenue And Forecasts To 2028 (US$ Million)

9.5         Academic and Research Institutes

9.5.1        Overview

9.5.2        Academic and Research Institutes - Market Revenue And Forecasts To 2028 (US$ Million)

10.        MEA Glycomics Market – Country Analysis

10.1.1     Overview

10.1.3     MEA Glycomics Market Revenue and Forecasts to 2028, By Country (%)

10.1.3.1       Saudi Arabia: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.3.1.1       Overview

10.1.3.1.2       Saudi Arabia: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.3.1.3       Saudi Arabia: Glycomics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.1.3.1.3.1    Saudi Arabia: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)

10.1.3.1.3.2    Saudi Arabia: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)

10.1.3.1.3.3    Saudi Arabia: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)

10.1.3.1.3.4    Saudi Arabia: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)

10.1.3.1.4       Saudi Arabia: Glycomics Market, by Application, 2019–2028 (US$ Million)

10.1.3.1.5       Saudi Arabia: Glycomics Market Revenue and Forecasts To 2028, By End User (US$ Million)

10.1.3.2       UAE: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.3.2.1       Overview

10.1.3.2.2       UAE: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.3.2.3       UAE: Glycomics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.1.3.2.3.1    UAE: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)

10.1.3.2.3.2    UAE: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)

10.1.3.2.3.3    UAE: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)

10.1.3.2.3.4    UAE: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)

10.1.3.2.4       UAE: Glycomics Market, by Application, 2019–2028 (US$ Million)

10.1.3.2.5       UAE: Glycomics Market Revenue and Forecasts To 2028, By End User (US$ Million)

10.1.3.3       South Africa: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.3.3.1       Overview

10.1.3.3.2       South Africa Glycomics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.3.3.3       South Africa: Glycomics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.1.3.3.3.1    South Africa: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)

10.1.3.3.3.2    South Africa: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)

10.1.3.3.3.3    South Africa: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)

10.1.3.3.3.4    South Africa: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)

10.1.3.3.4       South Africa: Glycomics Market, by Application, 2019–2028 (US$ Million)

10.1.3.3.5       South Africa: Metabolomics Market Revenue and Forecasts To 2028, By End User (US$ Million)

10.1.3.4       Rest of MEA: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.3.4.1       Overview

10.1.3.4.2       Rest of MEA: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.3.4.3       Rest of MEA: Glycomics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.1.3.4.3.1    Rest of MEA: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)

10.1.3.4.3.2    Rest of MEA: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)

10.1.3.4.3.3    Rest of MEA: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)

10.1.3.4.3.4    Rest of MEA: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)

10.1.3.4.4       Rest of MEA: Glycomics Market, by Application, 2019–2028 (US$ Million)

10.1.3.4.5       Rest of MEA: Metabolomics Market Revenue and Forecasts To 2028, By End User (US$ Million)

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      MERCK KGaA

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Agilent Technologies, Inc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      New England Biolabs

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Thermo Fisher Scientific Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Waters Corporation

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Bruker Corporation

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Takara Bio Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Shimadzu Corporation

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             MEA Glycomics Market, Revenue and Forecast, 2019–2028 (US$ Mn)

Table 2.             Saudi Arabia: Glycomics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 3.             Saudi Arabia: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)

Table 4.             Saudi Arabia: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)

Table 5.             Saudi Arabia: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)

Table 6.             Saudi Arabia: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)

Table 7.             Saudi Arabia: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Saudi Arabia: Glycomics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 9.             UAE: Glycomics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 10.          UAE: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)

Table 11.          UAE: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)

Table 12.          UAE: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)

Table 13.          UAE: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)

Table 14.          UAE: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 15.          UAE: Glycomics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 16.          South Africa Glycomics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 17.          South Africa: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)

Table 18.          South Africa: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)

Table 19.          South Africa: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)

Table 20.          South Africa: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)

Table 21.          South Africa: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 22.          South Africa: Metabolomics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 23.          Rest of MEA: Glycomics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 24.          Rest of MEA: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)

Table 25.          Rest of MEA: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)

Table 26.          Rest of MEA: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)

Table 27.          Rest of MEA: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)

Table 28.          Rest of MEA: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 29.          Rest of MEA: Metabolomics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 30.          Organic Developments in the Glycomics Market

Table 31.          Inorganic Developments in the Glycomics Market

Table 32.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           MEA Glycomics Market Segmentation

Figure 2.           MEA Glycomics Market, By Country

Figure 3.           MEA Glycomics Market Overview

Figure 4.           MEA Glycomics Market, By Product

Figure 5.           MEA Glycomics Market, By Country

Figure 6.           MEA: PEST Analysis

Figure 7.           MEA Glycomics Market Impact Analysis of Driver and Restraints

Figure 8.           MEA Glycomics Market – Revenue Forecast and Analysis

Figure 9.           MEA Glycomics Market, by Product 2022 & 2028 (%)

Figure 10.        MEA Enzymes Revenue and Forecasts to 2028 (US$ Million)

Figure 11.        MEA Glycosidases - Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        MEA Glycosyltransferases - Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        MEA Sialyltransferases - Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        MEA Neuraminidases - Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        MEA Others - Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        MEA Instruments - Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        MEA Mass Spectrometers - Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        MEA MALDI-TOF - Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        MEA High-Performance Liquid Chromatography (HPLC)- Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        MEA Lectin Arrays - Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        MEA Antibody Arrays - Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        MEA Others - Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        MEA Kits - Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        MEA Glycan Release Kits - Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        MEA Glycan Labelling Kits - Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        MEA Glycan Purification Kits - Revenue and Forecasts to 2028 (US$ Million)

Figure 27.        MEA Others - Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        MEA Reagents - Revenue and Forecasts to 2028 (US$ Million)

Figure 29.        MEA Oligosaccharides - Revenue and Forecasts to 2028 (US$ Million)

Figure 30.        MEA Monosaccharides - Revenue and Forecasts to 2028 (US$ Million)

Figure 31.        MEA Glycoproteins - Revenue and Forecasts to 2028 (US$ Million)

Figure 32.        MEA Others - Revenue and Forecasts to 2028 (US$ Million)

Figure 33.        MEA Glycomics Market, by Application 2022 & 2028 (%)

Figure 34.        MEA Drug Discovery and Development - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 35.        MEA Diagnostics - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 36.        MEA Immunology - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 37.        MEA Cancer - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 38.        MEA Others - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 39.        MEA Glycomics Market, by End User 2022 & 2028 (%)

Figure 40.        MEA Pharmaceutical and Biotechnology Companies - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 41.        MEA Contract Research Organizations - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 42.        MEA Academic and Research Institutes - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 43.        MEA Glycomics Market Revenue Overview, by Country, 2022 (US$ Million)

Figure 44.        MEA Glycomics Market Revenue and Forecasts to 2028, By Country (%)

Figure 45.        Saudi Arabia: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 46.        UAE: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 47.        South Africa: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 48.        Rest of MEA: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)

  1. Agilent Technologies, Inc.
  2. Bruker Corporation
  3. MERCK KGaA
  4. New England Biolabs
  5. Shimadzu Corporation    
  6. Takara Bio Inc.
  7. Thermo Fisher Scientific Inc.    
  8. Waters Corporation    
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000